Celltrion Advances Next-Generation Immuno-Oncology Candidate with Strong Preclinical Results
Celltrion has announced promising preclinical data for its investigational immuno-oncology candidate, CT-P72/ABP-102, demonstrating potent antitumor...
Search results for "Targeted Cancer Drugs"
Idience Targeted Cancer Drug Candidate ‘Venadaparib’ Granted FDA Fast Track Designation
Idience, a novel anticancer drug developer under the Ildong Pharmaceutical Group, announced on the 18th that its targeted cancer drug candidate...
Why Surgeons are Tracking the Rise of 'Pharmulator': The Next Frontier in Drug Development
The new drug development platform Pharmulator™ has officially made its debut on the international stage—not at a...
"Breast Cancer Diagnosis, It's Too Early to Give Up" A Doctor's Calm Comfort
"Many breast cancer patients struggle with the process of fighting the disease. This is likely due to the thought that...
Dr. Han Jin-hwan, Formerly of Merck (MSD), Appointed Head of New Drug Research Institute at Ligand Pharmaceuticals
Ligand Pharmaceuticals announced on the 5th that it has recruited Dr. Han Jin-hwan, formerly of Merck, as the head of...